全文获取类型
收费全文 | 85篇 |
免费 | 7篇 |
专业分类
儿科学 | 2篇 |
妇产科学 | 1篇 |
基础医学 | 6篇 |
临床医学 | 3篇 |
内科学 | 56篇 |
神经病学 | 1篇 |
外科学 | 2篇 |
药学 | 2篇 |
肿瘤学 | 19篇 |
出版年
2022年 | 2篇 |
2020年 | 1篇 |
2019年 | 1篇 |
2018年 | 2篇 |
2016年 | 1篇 |
2010年 | 1篇 |
2008年 | 1篇 |
2007年 | 3篇 |
2006年 | 3篇 |
2005年 | 2篇 |
2004年 | 1篇 |
2003年 | 2篇 |
2002年 | 1篇 |
2001年 | 7篇 |
2000年 | 5篇 |
1999年 | 11篇 |
1998年 | 3篇 |
1997年 | 6篇 |
1996年 | 6篇 |
1995年 | 4篇 |
1994年 | 1篇 |
1993年 | 4篇 |
1992年 | 4篇 |
1991年 | 9篇 |
1990年 | 2篇 |
1989年 | 4篇 |
1988年 | 3篇 |
1982年 | 1篇 |
1979年 | 1篇 |
排序方式: 共有92条查询结果,搜索用时 15 毫秒
1.
Nowadays, Facebook has become one of the most popular communication tools. With its increasing popularity, a new phenomenon connected with extensive use has appeared: namely, Facebook intrusion. The answer to the question of who is prone to become addicted still remains open. This study aimed to explore whether insufficient self-control and self-regulation resources in Facebook users are related to Facebook addiction. The participants in the study were 284 people. The Facebook Intrusion Questionnaire, the Brief Self-Control Scale, the Self-Regulation Scale, Action Control Scale, and the Multitasking Scale were used. We found that dysfunctional self-control system can be related to Facebook addiction. An insufficient self-control and low level of failure-related action orientation are those psychological characteristics that put Facebook users “at-risk” of Facebook addiction. The study reveals a picture showing that those Facebook users who are able to resist an impulse or temptation, are more self-disciplined, and do not focus on negative emotions are less likely to develop Facebook addiction. The obtained findings may serve as a basis for prevention programs for people at risk of Facebook addiction. 相似文献
2.
The effect of hematopoietic growth factors on neutrophil recovery after allogeneic transplantation is well-recognized. Recent laboratory studies demonstrated that these cytokines may also modify T-cell and dendritic cell function, but whether the effect is strong enough to alter the risk of GVHD is unclear. We performed a meta-analysis to determine the effect of G-CSF or GM-CSF on the risk of nonhematopoietic outcomes after allogeneic transplantation. A search of the literature from 1986 to present yielded 18 publications in which data were provided for cohorts receiving growth factor vs either placebo or no therapy. These included nine prospective randomized studies, eight retrospective cohort studies, and one case-control study comprising a total of 1198 patients. The publication types were heterogeneous with regard to demographic and treatment characteristics, although within publications, comparative groups were generally balanced. The pooled risk ratio estimates with use of growth factor was 1.08 (95% CI 0.87-1.33, P=0.48) for grades 2-4 acute GVHD, 1.22 (95% CI 0.80-1.86, P=0.99) for grades 3-4 acute GVHD, and 1.02 (95% CI 0.82-1.26, P=0.87) for chronic GVHD. This analysis did not detect a significant change in the risk of acute or chronic GVHD after allogeneic hematopoietic stem cell transplantation when hematopoietic growth factors were used to shorten the initial period of neutropenia. 相似文献
3.
4.
Engraftment of Allogeneic Hematopoietic Progenitor Cells With Purine Analog-Containing Chemotherapy: Harnessing Graft-Versus-Leukemia Without Myeloablative Therapy 总被引:30,自引:48,他引:30
Giralt Sergio; Estey Elihu; Albitar Maher; van Besien Koen; Rondon Gabriela; Anderlini Paolo; O'Brien Susan; Khouri Issa; Gajewski James; Mehra Rakesh; Claxton David; Andersson Borje; Beran Miloslav; Przepiorka Donna; Koller Charles; Kornblau Steve; Korbling Martin; Keating Michael; Kantarjian Hagop; Champlin Richard 《Blood》1997,89(12):4531-4536
5.
Przepiorka D Buadi F McClune B Franz G Walsh W White F 《Bone marrow transplantation》2007,40(8):759-764
Long-term survivors after autologous peripheral blood stem cell transplantation (APBSCT) for lymphoma or Hodgkin's disease are known to have a high risk of developing myelodysplastic syndrome (MDS), but the risk of MDS is not clear for patients transplanted for myeloma. We reviewed the outcomes for 82 myeloma patients who underwent APBSCT at our center. The group included 47 men and 35 women of median age 56 years (range: 37-74 years). Median time from diagnosis to APBSCT was 8.2 months (range: 2.6-86.1 months). Before coming to transplantation, 28% had received oral melphalan (MEL), 98% received other chemotherapy and 34% received radiation. A single APBSCT was provided for 68, and 32% underwent APBSCT more than once. High-dose MEL alone was used as the preparative regimen for 83%, and the remainder received at least one APBSCT with a more intensive preparative regimen. Ten patients (12%) developed MDS. The 5-year cumulative incidence is 18% (95% confidence interval, 9-30%). There were no demographic factors associated with an increased risk of developing MDS. Median survival after the diagnosis of MDS was 18 months. There is a relatively high risk of MDS after APBSCT for myeloma, and optimal therapy has not been established for these patients. 相似文献
6.
7.
Paolo Anderlini Donna Przepiorka David Seong Richard Champlin & Martin Körbling 《British journal of haematology》1996,94(1):155-158
Thirteen normal adult donors underwent daily leukapheresis for peripheral blood progenitor cell collection for allografting beginning on day 4 or 5 of G-CSF mobilization (12 μg/kg/d). They had complete blood counts performed 7–10 d after the completion of the procedure. A reduction in the total leucocyte count below baseline levels, accounted for by a decrease in the absolute neutrophil (ANC) and lymphocyte counts, was noted. Neutropenia (ANC < 1.5 × 109 /l) occurred in two (15%) of the donors. The lowest ANC observed was 0.6 × 109 /l. The neutropenia was asymptomatic and resolved on follow-up evaluation. 相似文献
8.
Abnormal methylation of the calcitonin gene marks progression of chronic myelogenous leukemia 总被引:8,自引:0,他引:8
The clinical aspects of disease progression in chronic myelogenous leukemia (CML) are well established, but the nature of the molecular events responsible is not known. We have previously reported a consistent pattern of novel sites of methylation in the 5' region of the calcitonin (CT) gene and other chromosome 11p loci in acute myelogenous and and lymphoid leukemias. In the present study, CT gene methylation patterns were investigated in peripheral blood from 51 patients with CML. Abnormal patterns were found in only 2 of 31 patients in chronic phase, but in 5 of 8 patients in accelerated phase, and in 11 of 12 patients in blast crisis (P less than .005). For one patient studied in blast crisis, abnormal CT gene methylation was found in the peripheral blast cells but not in the granulocytes. In two of three patients studied with CML and having normal peripheral cell patterns, abnormal patterns were found in marrow blast cells. In one patient, only partial normalization of the CT gene methylation pattern was seen after chemotherapy induction of a second chronic phase and the patient relapsed 5 months later. Our findings indicate that abnormal methylation of the 5' region of the CT gene is regularly a marker of disease progression in CML which may prove clinically useful. This abnormal methylation site is part of an imbalance in DNA methylation that may play a role in the progressive genetic instability which characterizes the advancing stages of CML. 相似文献
9.
10.
Chimerism studies using in situ hybridization for the Y chromosome after T cell-depleted bone marrow transplantation 总被引:1,自引:0,他引:1
D Przepiorka R Gonzales-Chambers A Winkelstein C Rosenfeld R K Shadduck 《Bone marrow transplantation》1990,5(4):253-257
In situ hybridization for the Y chromosome (Y-ISH) was used to monitor engraftment in 10 patients with hematological malignancies who had received T cell-depleted marrow transplants from sex-mismatched donors, seven of whom were only partially HLA-matched. In the three patients who engrafted, as the peripheral counts rose, the percentage of host peripheral blood and marrow mononuclear cells decreased steadily, although host cells (less than 1%) could still be detected as late as day 252. The percentage of host granulocytes fell rapidly to less than 0.2%. Seven patients did not achieve full engraftment by day 28. Those with a low percentage of host cells (less than 1%) improved with observation or treatment with steroids, while those with a high or increasing percentage of host cells did not improve even after treatment with GM-CSF or with repeat marrow infusion without reconditioning. In one patient with graft failure, the residual host cells were predominantly CD8+ CD57+ and CD3+ CD56+, phenotypes consistent with non-MHC-restricted cytotoxic T cells. Lack of full engraftment in recipients of T cell-depleted marrow is not always associated with autologous reconstitution and does not always require retransplantation. Y-ISH may be useful for monitoring patients at high risk for graft failure in order to detect adverse trends in mixed chimerism that will alter therapy early after transplantation. 相似文献